The application provides a unipolar cannula that can have a metal cannula tube, a body part made of an electrically insulating plastic, attached to the proximal end of the cannula tube, a connector disposed on the body part for the introduction of a liquid into the cannula tube, and a stimulation cable, an electroconductive wire of which electrically contacts the cannula tube in the region of the body part. The stimulation cable can be mounted laterally on the body part by a mounting part made of an electrically insulating plastic, where the mounting part has an electroconductive contact element which is connected conductively to the wire, and where the contact element engages into a recess of the body part and contacts the cannula tube when the mounting part is mounted on the body part.

Described herein are treatment tip apparatuses (e.g., devices, systems, etc.) including one, or more preferably a plurality, of electrodes that are protected by an electrode partition, such as an electrode housing (which may be retractable) until pressed against the tissue for deployment of the electrodes and delivery of a therapeutic treatment. In particular, these apparatuses may include a plurality of treatment electrodes (e.g., needle electrodes) and be configured for the delivery of nanosecond pulsed electric fields.

The inventive concept provides a mouthpiece for treating skin, in which a retaining ligament, a blood vessel, and a fiber tissue of a deep skin portion may be used as electrical passages, and which is manufactured in accordance with an oral cavity structure of a patient, and a skin treating apparatus including the mouthpiece for treating skin. The mouthpiece for treating skin includes an impression body disposed in an oral cavity of a user, and a first electrode unit disposed in the impression body, wherein the first electrode unit electrically interacts with a second electrode unit disposed outside the oral cavity of the user, and the impression body has a shape corresponding to a structure of the oral cavity of the user.

A wearable, percutaneous device for suppressing appetite or hunger in a patient includes a microprocessor, electrical stimulator and at least one percutaneous electrode implanted and configured to deliver electrical stimulation through the patient's skin. The percutaneous device includes a pad and at least one needle, in which the electrode is disposed, for secure placement of the device within the skin of a patient. The percutaneous device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.

An auricular nerve field stimulation device may include a first plurality of electrodes arranged to contact a ventral aspect of an auricle, a second plurality of electrodes arranged to contact a dorsal aspect of the auricle, and electrical circuitry coupled to the electrodes and configured to selectively apply electrical stimulation signals to the electrodes to cause a first set of trans-auricular currents to flow through the auricle between the first plurality of electrodes and respective ones of the second plurality of electrodes paired therewith according to a first pairing, and to cause a second set of trans-auricular currents to flow through the auricle between the first plurality of electrodes and respective ones of the second plurality of electrodes paired therewith according to a second pairing different from the first pairing, the first and second sets of trans-auricular currents to stimulate at least one auricular nerve field within the auricle.

A method of managing pain related to a peripheral nerve injury of a subject comprises delivering stimulation energy of a first frequency to the target nerve via at least one electrode assembly during a regenerative phase and delivering stimulation energy of a second frequency for a predetermined period via the at least one electrode assembly during at least one neuropathic pain management phase.

Embodiments of medical treatment including skin treatment using electrical energy, especially with the primary purpose for skin treatment for aesthetics are described generally herein. Other embodiments may be described and claimed.

An electro-stimulation apparatus provides stimulation of the supplementary motor area, premotor area, cerebellum and/or subthalamic nucleus of a human. The electro-stimulation apparatus includes at least one micro needle electrode having a stimulation end and a base. Said at least one micro needle electrode is provided with a stimulation end configured to stimulate intrinsic auricular muscles of the human and said stimulation end of said micro needle electrode is adapted to generate an electrical stimulation signal during a stimulating state.

Gamification for a pelvic disorder regimen has a processor for operating a control module configured to define a programmable treatment regimen. A neurostimulator is connected to the processor and the control module. The neurostimulator applies electrical or magnetic signals to the user according to the programmable treatment regimen which includes at least one treatment task to be performed by the user. A gramification module calculates and stores a set of scores of the user in performing at least one task defined in the programmable treatment program associated with one or more events defined in the programmable treatment program to provide a score assigned to each task performance. A user interface is connected to the control module and provides the user with information associated with the scores attained by the user.

Disclosed herein is a pulse generator device for trigeminal nerve stimulation. In one embodiment, the pulse generator device comprises a processor(s) configured to: produce pulses delivered to an electrode assembly for a therapy session(s) for a patient, log data from the therapy session(s) (where the data comprises impedance of the electrode assembly connected to the pulse generator and current amplitude of the pulses), determine an average current amplitude from the data, determine an average therapy impedance from the data, determine a charge capacity of a battery of the pulse generator prior to beginning a subsequent therapy session, determine whether the charge capacity of the battery is sufficient to complete the subsequent therapy session for a designated duration of time by using the average current amplitude and the average therapy impedance. Further the pulse generator device comprises a display configured to display a screen comprising a graphical user interface (GUI).